Nkx2-2 Antikörper
Kurzübersicht für Nkx2-2 Antikörper (ABIN6252568)
Target
Alle Nkx2-2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Protein A affinity chromatography
-
Immunogen
- A human partial recombinant protein was used as the immunogen for this NKX2.2 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Flow Cytometry: 0.5-1 μg/10e6 cells in 0.1ml
IF: 1-2 μg/mL
IHC (FFPE): 1-2 μg/mL for 30 minutes at RT
Titering of the NKX2.2 antibody may be required for optimal performance. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
-
- Nkx2-2 (NK2 Homeobox 2 (Nkx2-2))
-
Andere Bezeichnung
- NKX2.2
-
Hintergrund
- Expression of NKX2.2 has been found in neuroendocrine tumors of the gut, making it a potential marker for the study of gastrointestinal neuroendocrine tumors. More recently, NKX2.2 protein was identified as a target of EWS-FLI-1, the fusion protein specific to Ewing sarcoma, and was shown to be differentially upregulated in Ewing sarcoma on the basis of array-based gene expression analysis. Antibody to NKX2.2 detects a valuable marker for Ewing sarcoma, with a sensitivity of 93 % and a specificity of 89 %, and aids in the differential diagnosis of small round cell tumors.
-
Gen-ID
- 4821
-
UniProt
- O95096
-
Pathways
- Dopaminergic Neurogenesis
Target
-